SEATTLE GENETICS INC (73)

Browse by Contract Category

Contracts

Amendment No. 1 to Commercial Supply Agreement dated June 17, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Corden Pharma GmbH (Filed With SEC on July 28, 2022)
Form of Stock Option Agreement for Non-Employee Directors under the Amended and Restated 2007 Equity Incentive Plan (Approved February 10, 2022) (Filed With SEC on April 28, 2022)
License Agreement dated as of August 8, 2021 between RemeGen Co., Ltd. and Seagen Inc (Filed With SEC on September 21, 2021)
Lease Agreement dated June 21, 2021 between Seagen Inc. and DPIF2 WA 7 Mountain View, LLC (Filed With SEC on July 29, 2021)
Letter Agreement Regarding Royalty between the University of Miami and Seagen Inc. (f/k/a (Filed With SEC on July 29, 2021)
Amended and Restated 2000 Employee Stock Purchase Plan, effective March 12, 2021 (Filed With SEC on April 29, 2021)
Thirteenth Amendment to Development and Supply Agreement, effective May 12, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and AbbVie Inc. (formerly part of Abbott... (Filed With SEC on July 28, 2022)
Form of Stock Unit Grant Notice and Stock Unit Agreement for Non-employee Directors under the Amended and Restated 2007 Equity Incentive Plan (Approved February 10, 2022) (Filed With SEC on April 28, 2022)
Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement under the Amended and Restated 2007 Equity Incentive Plan (approved January 18, 2022) (Filed With SEC on February 9, 2022)
Amended and Restated Employment Agreement dated February 9, 2022, between Seagen Inc. and Todd Simpson (Filed With SEC on February 9, 2022)
Amended and Restated Employment Agreement dated (Filed With SEC on February 9, 2022)
Amended and Restated Employment Agreement dated (Filed With SEC on February 9, 2022)
Amended and Restated Employment Agreement dated February 9, 2022, between Seagen Inc. and (Filed With SEC on February 9, 2022)
Amended and Restated Employment Agreement dated (Filed With SEC on February 9, 2022)
Amended and Restated Employment Agreement dated (Filed With SEC on February 9, 2022)
Tenth Amendment to Development and Supply Agreement, effective as of December 26, 2016 between (Filed With SEC on February 9, 2022)
Collaboration and License Agreement dated January 7, 2007 between (Filed With SEC on February 9, 2022)
Form of Stock Option Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)
Ninth Amendment to Development and Supply Agreement effective as of August 28, 2016 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and AbbVie Inc. (formerly part of Abbott... (Filed With SEC on October 28, 2021)
Commercial Supply Agreement between Hovione Farmaciencia, SA and Seagen Inc. dated July 1, 2021 (Filed With SEC on October 28, 2021)
Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement for employees under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)
Form of Stock Option Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)
Form of Stock Unit Grant Notice and Stock Unit Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)
Form of Stock Unit Grant Notice and Stock Unit Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)
Amendment to Joint Commercialization Agreement between Seagen Inc. and Agensys, Inc. effective January 1, 2020 (Filed With SEC on July 29, 2021)
Form of Stock Option Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)
Office lease dated May 9, 2011 between Seagen Inc. (f/k/a Seattle Genetics Inc.) and WCM Highlands II LLC (Filed With SEC on April 29, 2021)
Third Amendment to Lease dated May 9, 2011 between Seagen Inc. (f/k/a Seattle Genetics Inc.) and B&N 141-302, LLC (Filed With SEC on April 29, 2021)
Form of Stock Option Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)
Form of Stock Unit Grant Notice and Stock Unit Agreement for French Grantees under the Amended and Restated 2007 Equity Incentive Plan (approved March 8,2021) (Filed With SEC on April 29, 2021)
Form of Stock Option Agreement for Non-Employee Directors under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)
Form of Time-Based Stock Unit Grant Notice and Stock Unit Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)
Form of Stock Unit Grant Notice and Stock Unit Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)
Form of Stock Unit Grant Notice and Stock Unit Agreement for non-employee directors under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)
Sixth Amendment to Development and Supply Agreement dated November 18, 2010 between (Filed With SEC on February 12, 2021)
Senior Executive Annual Bonus Plan, as amended February 9, 2021 (Filed With SEC on February 12, 2021)
Second Amendment to Commercial Supply Agreement effective as of December 2, 2016 between (Filed With SEC on February 12, 2021)
Commercial Supply Agreement dated December 1, 2010 between (Filed With SEC on February 12, 2021)
Joint Commercialization Agreement dated October 19, 2020 between Genmab A/S and Seagen Inc. (f.k.a. Seattle Genetics Inc.) (Filed With SEC on February 12, 2021)
Specimen Stock Certificate (Filed With SEC on February 12, 2021)
First Amendment to Commercial Supply Agreement effective as of January 20, 2014 between (Filed With SEC on February 12, 2021)
Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement under the (Filed With SEC on October 30, 2020)
Stock Purchase Agreement dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)
License and Collaboration Agreement relating to ladiratuzumab vedotin dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)
Commercial Supply Agreement dated June 13, 2019 between Seattle Genetics, Inc. and Esteve Quimica, S.A (Filed With SEC on July 31, 2020)
Seattle Genetics, Inc. Equity Incentive Plan, effective as of May 15, 2020 (Filed With SEC on July 31, 2020)
Amendment No. 1 (Filed With SEC on July 31, 2020)
Commercial Supply Agreement dated April 2, 2020 between Seattle Genetics, Inc. and Sterling Pharma Solutions Limited (Filed With SEC on July 31, 2020)
Amendment No. 1 to License Agreement dated April 23, 2020 between Cascadian Therapeutics, Inc. and Array BioPharma, Inc (Filed With SEC on July 31, 2020)
Commercial Supply Agreement dated February 20, 2020 between Seattle Genetics, Inc. and Corden Plankstadt (Filed With SEC on July 31, 2020)
Amended and Restated Employment Agreement dated April 15, 2020 between Seattle Genetics, Inc. and Charles Romp (Filed With SEC on July 31, 2020)
Form of Stock Option Agreement for Non-U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved March 13, 2020) (Filed With SEC on April 30, 2020)
Rules of the Seattle Genetics Inc. Amended and Restated 2007 Equity Incentive Plan for Restricted Stock Unit Awards Granted to French Grantees effective as of March 13, 2020 (Filed With SEC on April 30, 2020)
Form of Stock Unit Grant Notice and Stock Unit Agreement for French Grantees under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved March 13,... (Filed With SEC on April 30, 2020)
Form of Stock Option Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved March 13, 2020) (Filed With SEC on April 30, 2020)
Form of Stock Unit Grant Notice and Stock Unit Agreement for non-US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved... (Filed With SEC on February 6, 2020)
Description of Securities of Seattle Genetics, Inc (Filed With SEC on February 6, 2020)
Eleventh Amendment to Development and Supply Agreement effective July 12, 2018 between Seattle Genetics, Inc. and AbbVie Inc. (formerly part of Abbott Laboratories, Inc.) (Filed With SEC on February 6, 2020)
Form of Stock Option Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December 19, 2019) (Filed With SEC on February 6, 2020)
Form of Stock Option Agreement for Non-US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December 19, 2019) (Filed With SEC on February 6, 2020)
Form of Time-Based Stock Unit Grant Notice and Stock Unit Agreement for employees under Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December... (Filed With SEC on February 6, 2020)
Form of Stock Unit Grant Notice for Non-US Participants Long Term Incentive Plan for EV and TV (approved December 19, 2019) (Filed With SEC on February 6, 2020)
Form of Performance-Based Stock Unit Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December 19, 2019) (Filed With SEC on February 6, 2020)
Form of Stock Unit Grant Notice for US Participants Long Term Incentive Plan for EV and TV (approved December 19, 2019) (Filed With SEC on February 6, 2020)
Form of Performance-Based Stock Unit Notice and Stock Unit Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan... (Filed With SEC on February 6, 2020)
Form of Performance-Based Stock Unit Notice and Stock Unit Agreement for Non-U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan... (Filed With SEC on February 6, 2020)
Collaboration Agreement between Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc. (a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited) dated December 14,... (Filed With SEC on February 6, 2020)
Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved August 26,... (Filed With SEC on October 30, 2019)
Third Amendment to Commercial Supply Agreement effective as of July 1, 2019 between Seattle Genetics, Inc. and SAFC, an operating division of Sigma-Aldrich, Inc (Filed With SEC on October 30, 2019)
Employment Agreement, dated May 20, 2019, between Seattle Genetics, Inc. and Robin Taylor (Filed With SEC on July 16, 2019)
Twelfth Amendment to Development and Supply Agreement, effective as of April 25, 2019 between Seattle Genetics, Inc. and AbbVie, Inc. (formerly part of Abbott Laboratories, Inc.) (Filed With SEC on July 16, 2019)
Joint Commercialization Agreement dated October 20, 2018 between Seattle Genetics, Inc. and Agensys, Inc (Filed With SEC on July 16, 2019)
Seattle Genetics, Inc. Senior Executive Annual Bonus Plan, effective February 4, 2019 (Filed With SEC on February 7, 2019)